Results 141 to 150 of about 1,865 (185)

PARATHYROID CANCER: REVIEW OF UNCOMMON DISEASE. [PDF]

open access: yesActa Endocrinol (Buchar)
Yabanoglu H, Arer IM, Ozarslan F.
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Renal handling of biphosphonate alendronate in rats

Biopharmaceutics & Drug Disposition, 1999
Alendronate is a bisphosphonate that is secreted via a saturable pathway in rat kidney. This study is designed to discover if the rate-determining step in its net renal secretion is uptake into the renal tubule. The tissue uptake clearance of alendronate by the kidney, estimated from an integration plot analysis and normalized with respect to plasma ...
I, Kino, Y, Kato, J H, Lin, Y, Sugiyama
openaire   +2 more sources

Implants and biphosphonates: 2012 guidelines for practitioners

Revue de Stomatologie, de Chirurgie Maxillo-faciale et de Chirurgie Orale, 2013
Revue de Stomatologie, de Chirurgie Maxillo-Faciale et de Chirurgie Orale - Vol. 114 - N° 1 - p.
openaire   +3 more sources

Les biphosphonates dans l’ostéogenèse imparfaite

Archives de Pédiatrie, 2009
Used for more than 10 years in addition to physiotherapy, orthopaedic surgery and rehabilitation, biphosphonate therapy has transformed the management of children with severe or moderate form of osteogenesis imperfecta. The authors of this article report indications, administration's way, duration and safety of biphosphonate therapy with uncertainties ...
openaire   +1 more source

[Biphosphonates and intraocular inflammation].

Archivos de la Sociedad Espanola de Oftalmologia, 2004
PURPOSE/MATERIAL AND METHOD: A 67 year old woman had been taking oral alendronate in a single weekly dose of 70 mg. She developed panuveitis in her right eye and anterior uveitis in the left. The uveitis was resolved with steroids and discontinuation of alendronate. Three weeks later alendronate was reinstituted and this produced a recurrence. Her past
V M, Asensio Sánchez   +2 more
openaire   +1 more source

Cancer du sein et biphosphonates

2008
Les biphosphonates (BP) sont des molecules analogues du pyrophosphate capables d’inhiber l’activite osteoclastique. Il es actuellement decrit deux grandes familles de BP: les non amino-biphosphonates (formation de metabolites cytotoxiques induisant l’apotose des osteoclastes) et les amino-biphosphonates (inhibition de la voie du nevalonate) qui ...
M. Campone   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy